Zobrazeno 1 - 4
of 4
pro vyhledávání: '"59"'
Autor:
Alfred J. Saah, Ronald T. Mitsuyasu, Elizabeth A. Stier, Mark H. Einstein, J. Michael Berry, David M. Aboulafia, Shelly Lensing, Timothy J. Wilkin, Stephen E. Goldstone, David L. Cohn, Naomi Jay, Joel M. Palefsky, Jeannette Y. Lee
Publikováno v:
The Journal of Infectious Diseases. 202:1246-1253
Background Human immunodeficiency virus type 1 (HIV-1)-infected men are at increased risk for anal cancer. Human papillomavirus (HPV) vaccination may prevent anal cancer caused by vaccine types. Methods AIDS Malignancy Consortium Protocol 052 is a si
Autor:
Zabrina L. Brumme, Marianne Harris, Richard Harrigan, Julio S. G. Montaner, Adrienne R. Toulson, Katherine V. Heath, Robert S. Hogg, Benita Yip
Publikováno v:
The Journal of infectious diseases. 192(10)
The goal of the present study was to characterize outcome and predictors of outcome of treatment interruption (TI) in highly active antiretroviral therapy (HAART)-treated patients.A systematic chart/database review was conducted to identify patients
Publikováno v:
The Journal of infectious diseases. 190(1)
Background. High rates of persistence of human papillomavirus (HPV) infection have been reported for adult women with human immunodeficiency virus (HIV) infection. Although most women are first infected with HPV during adolescence, persistence of spe
Autor:
Anna Wald, Sylvie Trottier, Mohsen Shahmanesh, Joanne Hill, Terri Warren, Clare A. Brennan, Edwin DeJesus, Timothy W. Schacker
Publikováno v:
The Journal of infectious diseases. 188(7)
To determine the efficacy and safety of valacyclovir (500 mg twice daily) for the suppression of recurrent genital herpes simplex virus infections in human immunodeficiency virus (HIV)-infected subjects, a randomized, double-blind, placebo-controlled